Figure 1.
Clinical features associated with early progression in LBCL treated with CAR-19. (A) Follow-up and clinical outcome of 47 of 49 patients with LBCL included in the PFS and OS analysis (excluded cases: relapse-only sample with transitory complete remission and early therapy-related death not evaluable for PFS). Red arrows indicate ongoing responses. (B) Kaplan-Meier curve for PFS for all 47 patients. (C-D) Kaplan-Meier curves for PFS comparing female vs male (C), patients more or less than 65 years old (D), and low vs high MTV (E).

Clinical features associated with early progression in LBCL treated with CAR-19. (A) Follow-up and clinical outcome of 47 of 49 patients with LBCL included in the PFS and OS analysis (excluded cases: relapse-only sample with transitory complete remission and early therapy-related death not evaluable for PFS). Red arrows indicate ongoing responses. (B) Kaplan-Meier curve for PFS for all 47 patients. (C-D) Kaplan-Meier curves for PFS comparing female vs male (C), patients more or less than 65 years old (D), and low vs high MTV (E).

Close Modal

or Create an Account

Close Modal
Close Modal